Basiliximab Injectable Solution 20 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 20 mg/vial
Reference Brands: Simulect(US)
Category: Transplant
Basiliximab is a monoclonal antibody that targets the IL-2 receptor on activated T-cells, inhibiting their proliferation and immune response. It effectively reduces organ rejection in transplantation, supporting graft survival. Benefits include targeted immunosuppression, decreased rejection risk, and improved transplant outcomes, enhancing long-term graft function and patient survival.
Product Description: Basiliximab injection, marketed as Simulect, is approved in the US by the FDA and in the EU via EMA for preventing organ rejection in kidney transplantation. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews extensive clinical trial and quality data, while the EMA ensures compliance with safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe use, and broad availability, helping transplant patients achieve graft survival and improve long-term outcomes worldwide.
Basiliximab Injectable Solution — third party manufacturing & bulk supply
Basiliximab Injectable Solution 20 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Basiliximab Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Basiliximab Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Basiliximab Injectable Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Cotrimoxazole 800Mg Tablets
Strength:
80 mg trimethoprim / 400 mg sulfamethoxazole
Form: Tablets
Reference Brands: Bactrim, Septra(US & EU)
View Details
Acyclovir Tablet
Strength:
200 mg, 400 mg, 800 mg
Form: Tablets
Reference Brands: Zovirax(US & EU)
View Details
Belatacept Injection
Strength:
250 mg/vial
Form: Injection
Reference Brands: Nulojix(US)
View Details
Quick Response Guaranteed | Verified Suppliers
